Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

International Business Machine’s Outperformance Is Poised to Continue

By Larry Ramer, InvestorPlace Contributor

Going forward, IBM stock should get boosts from margins gains and the acceleration of its revenue growth, enabling it to keep outperforming.

A Major Threat and an Unknown Undermine Zillow’s Outlook

By Larry Ramer, InvestorPlace Contributor

With the housing market facing a major threat and the outcome of Zillow's strategic switch questionable, it's best to avoid ZG stock.

Bionano Stock Looks to Have a Monster Comeback in Its Future

By Larry Ramer, InvestorPlace Contributor

Bionano's Saphyr appears to be able to help doctors treat leukemia more effectively, and adoption of its device is growing rapidly. BNGO stock is a buy.

3 Desirable Drug Stocks With Very Promising Pipelines

By Larry Ramer, InvestorPlace Contributor

Drug makers with superb pipelines are likely to deliver great returns for long-term investors. Here are three drug stocks to consider.

3 More Reasons Why Sofi Technologies’ Struggles Will Likely Continue

By Larry Ramer, InvestorPlace Contributor

Sofi is facing significant macro challenges and the valuation of SOFI stock remains very high. As a result, the shares are not attractive.

Load More